COMPANY

Brimrose Technology Corp.

Profile checked Oct 10, 2026

Keywords: Pneumonic Plague Plague Bubonic Plague Yersinia Pestis Plague Yersinia Sepsis Yersinia Pestis Infection stroke

Timeline

Oct 19, 2020 Trial start —: Yersinia Pestis Lateral Flow Immunoassay for Blood Samples source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT04688996	Yersinia Pestis Lateral Flow Immunoassay for Blood Samples	Not listed	Unknown status (ClinicalTrials.gov)	Oct 19, 2020	2022-12 (estimated)

Annual award amounts. Total $794K.

Sep 23, 2022 NIH award 1R41EB033751-01 FY2022: $300,000 awarded for that fiscal year; activity R41 (STTR); PI TRIVEDI, SUDHIR B; recipient as written: BRIMROSE TECHNOLOGY CORPORATION, SPARKS, MD. A Normal Paradigm to Monitor Peri source ↗
Sep 2, 2022 NIH award 1R41EB033758-01 FY2022: $344,468 awarded for that fiscal year; activity R41 (STTR); PI JIN, FENG; recipient as written: BRIMROSE TECHNOLOGY CORPORATION, SPARKS, MD. Continuous Photoacoustic Monitoring of Ne source ↗
Jun 18, 2020 NIH award 1R43HD102260-01 FY2020: $149,978 awarded for that fiscal year; activity R43 (SBIR); PI WANG, CHENCHIA; recipient as written: BRIMROSE TECHNOLOGY CORPORATION, SPARKS, MD. New Photo-Acoustic Imaging Process i source ↗